Form 4: Atea Pharmaceuticals Director Jerome M. Adams Reports Stock Unit Conversion
SEC Form 4
Director Jerome M. Adams reports the conversion of restricted stock units into common stock of Atea Pharmaceuticals.
Summary
- On June 16, 2024, Jerome M. Adams, a director of Atea Pharmaceuticals, Inc. converted 33,150 restricted stock units into common stock.
- The restricted stock units converted on a one-for-one basis and were fully vested.
- The transaction was reported on June 18, 2024.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing. It reports a standard transaction and doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes.
Stakeholder Impact
- The conversion of restricted stock units into common stock may have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/16/2024 | Date of transaction: conversion of restricted stock units to common stock |
| 06/18/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.